Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

A male with aromatase deficiency improved bone health with estradiol treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.